Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Ghany MG, Marks KM, Morgan TR, Wyles DL, Aronsohn AI, Bhattacharya D, Broder T, Falade-Nwulia OO, Feld JJ, Gordon SC, Heller T, Jhaveri RR, Jonas MM, Kiser JJ, Linas BP, Lo Re V, Peters MG, Reddy KR, Reynolds A, Scott JD, Searson G, Spradling P, Terrault NA, Trooskin SB, Verna EC, Wong JB, Woolley AE, Workowski KA.

Hepatology. 2019 Dec 9. doi: 10.1002/hep.31060. [Epub ahead of print]

PMID:
31816111
2.

Resting-State Functional Magnetic Resonance Imaging for Brain Tumor Surgical Planning: Feasibility in Clinical Setting.

Sparacia G, Parla G, Cannella R, Perri A, Lo Re V, Mamone G, Miraglia R, Torregrossa F, Grasso G.

World Neurosurg. 2019 Nov;131:356-363. doi: 10.1016/j.wneu.2019.07.022.

PMID:
31658578
3.

Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.

Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V  III.

Cancer Epidemiol Biomarkers Prev. 2019 Oct 1. doi: 10.1158/1055-9965.EPI-19-0503. [Epub ahead of print]

PMID:
31575557
4.

Advanced magnetic resonance imaging of cortical laminar necrosis in patients with stroke.

Cannella R, Sparacia G, Lo Re V, Oddo E, Mamone G, Miraglia R.

Neuroradiol J. 2019 Dec;32(6):431-437. doi: 10.1177/1971400919876621. Epub 2019 Sep 30.

PMID:
31566507
5.

Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies.

Saine ME, Carbonari DM, Newcomb CW, Gallagher AM, Blak BT, Roy JA, Wood J, Cardillo S, Hennessy S, Strom BL, Lo Re V 3rd.

Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1328-1335. doi: 10.1002/pds.4853. Epub 2019 Jul 22.

PMID:
31328342
6.

Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.

Lo Re V 3rd, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN; North American AIDS Cohort Collaboration on Research and Design of IeDEA.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):71-80. doi: 10.1097/QAI.0000000000002094.

PMID:
31107304
7.

Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.

Torgersen J, So-Armah K, Freiberg MS, Goetz MB, Budoff MJ, Lim JK, Taddei T, Butt AA, Rodriguez-Barradas MC, Justice AC, Kostman JR, Lo Re V 3rd.

BMC Gastroenterol. 2019 Apr 15;19(1):52. doi: 10.1186/s12876-019-0969-1.

8.

Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

Sawinski D, Forde KA, Lo Re V 3rd, Goldberg DS, Cohen JB, Locke JE, Bloom RD, Brensinger C, Weldon J, Shults J, Reese PP.

Am J Kidney Dis. 2019 Jun;73(6):815-826. doi: 10.1053/j.ajkd.2018.11.009. Epub 2019 Jan 29.

PMID:
30704882
9.

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, Rabkin CS, Klein DB, Lo Re V, Sterling TR, Desir FA, Lichtenstein K, Willig J, Rachlis AR, Kirk GD, Anastos K, Palella FJ Jr, Thorne JE, Eron J, Jacobson LP, Napravnik S, Achenbach C, Mayor AM, Patel P, Buchacz K, Jing Y, Gange SJ; North American AIDS Cohort Collaboration on Research and Design.

Lancet HIV. 2019 Feb;6(2):e93-e104. doi: 10.1016/S2352-3018(18)30295-9. Epub 2019 Jan 22. Erratum in: Lancet HIV. 2019 Apr 2;:.

PMID:
30683625
10.

Neurological complications after cardiac surgery: a retrospective case-control study of risk factors and outcome.

Raffa GM, Agnello F, Occhipinti G, Miraglia R, Lo Re V, Marrone G, Tuzzolino F, Arcadipane A, Pilato M, Luca A.

J Cardiothorac Surg. 2019 Jan 25;14(1):23. doi: 10.1186/s13019-019-0844-8.

11.

Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States.

Gowda C, Lo Re V 3rd.

Curr Hepatol Rep. 2018 Jun;17(2):111-120. doi: 10.1007/s11901-018-0394-x. Epub 2018 Mar 24.

12.

Guillain-Barré syndrome after orthotopic liver transplantation: A clinical manifestation of immune reconstitution inflammatory syndrome?

Lo Re V, Petridis I, Živković S, Burgio G, Mularoni A, Milazzo M, Sparacia G, Volpes R, Luca A, Gruttadauria S.

Clin Neurol Neurosurg. 2018 Oct;173:140-143. doi: 10.1016/j.clineuro.2018.07.021. Epub 2018 Aug 10.

PMID:
30125836
13.

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study.

Gowda C, Lott S, Grigorian M, Carbonari DM, Saine ME, Trooskin S, Roy JA, Kostman JR, Urick P, Lo Re V 3rd.

Open Forum Infect Dis. 2018 Jun 7;5(6):ofy076. doi: 10.1093/ofid/ofy076. eCollection 2018 Jun.

14.

Brain-core temperature of patients before and after orthotopic liver transplantation assessed by DWI thermometry.

Sparacia G, Cannella R, Lo Re V, Mamone G, Sakai K, Yamada K, Miraglia R.

Jpn J Radiol. 2018 May;36(5):324-330. doi: 10.1007/s11604-018-0729-0. Epub 2018 Mar 19.

PMID:
29556899
15.

Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.

Justice AC, Gordon KS, Skanderson M, Edelman EJ, Akgün KM, Gibert CL, Lo Re V 3rd, Rimland D, Womack JA, Wyatt CM, Tate JP; VACS Project Team.

AIDS. 2018 Mar 27;32(6):739-749. doi: 10.1097/QAD.0000000000001756.

16.

Assessment of cerebral microbleeds by susceptibility-weighted imaging at 3T in patients with end-stage organ failure.

Sparacia G, Cannella R, Lo Re V, Gambino A, Mamone G, Miraglia R.

Radiol Med. 2018 Jun;123(6):441-448. doi: 10.1007/s11547-018-0863-x. Epub 2018 Feb 17.

PMID:
29455423
17.

Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs.

Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL, Lo Re V 3rd.

Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1147-1150. doi: 10.1002/pds.4368. Epub 2017 Dec 18.

PMID:
29250905
18.

The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.

Li DK, Ren Y, Fierer DS, Rutledge S, Shaikh OS, Lo Re V 3rd, Simon T, Abou-Samra AB, Chung RT, Butt AA.

Hepatology. 2018 Jun;67(6):2244-2253. doi: 10.1002/hep.29707. Epub 2018 Apr 19.

PMID:
29205416
19.

Is Moderate Alcohol Consumption Safe for Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women?

Lo Re V 3rd.

Clin Infect Dis. 2017 Nov 29;65(12):2057-2059. doi: 10.1093/cid/cix720. No abstract available.

20.

Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.

Byrne DD, Tate JP, Forde KA, Lim JK, Goetz MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Bedimo R, Freiberg MS, Justice AC, Kostman JR, Roy JA, Lo Re V 3rd.

Clin Infect Dis. 2017 Oct 16;65(9):1542-1550. doi: 10.1093/cid/cix564.

21.

Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study.

Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D'souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V 3rd.

Liver Int. 2018 May;38(5):813-820. doi: 10.1111/liv.13594. Epub 2017 Sep 30.

PMID:
28941137
22.

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.

BMJ Open Diabetes Res Care. 2017 Jul 31;5(1):e000400. doi: 10.1136/bmjdrc-2017-000400. eCollection 2017.

23.

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study.

Ragonese P, Aridon P, Vazzoler G, Mazzola MA, Lo Re V, Lo Re M, Realmuto S, Alessi S, D'Amelio M, Savettieri G, Salemi G.

BMC Neurol. 2017 Aug 8;17(1):155. doi: 10.1186/s12883-017-0932-0.

24.

The Reply.

Lo Re V 3rd, Carbonari DM, Lewis JD, Roy JA, Corley DA.

Am J Med. 2017 Aug;130(8):e369. doi: 10.1016/j.amjmed.2017.03.062. No abstract available.

PMID:
28734384
25.

HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.

Taylor BS, So-Armah K, Tate JP, Marconi VC, Koethe JR, Bedimo RJ, Butt AA, Gibert CL, Goetz MB, Rodriguez-Barradas MC, Womack JA, Gerschenson M, Lo Re V 3rd, Rimland D, Yin MT, Leaf D, Tracy RP, Justice AC, Freiberg MS.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):500-508. doi: 10.1097/QAI.0000000000001444.

26.

FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.

So-Armah KA, Lim JK, Lo Re V, Tate JP, Chang CH, Butt AA, Gibert CL, Rimland D, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Budoff MJ, Tindle HA, Samet JH, Justice AC, Freiberg MS; Veterans Aging Cohort Study Project Team.

Hepatology. 2017 Oct;66(4):1286-1295. doi: 10.1002/hep.29285. Epub 2017 Aug 30.

27.

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.

Gowda C, Newcomb CW, Liu Q, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Roy JA, Marks AR, Schneider JL, Kostman JR, Tate JP, Lim JK, Justice AC, Goetz MB, Corley DA, Lo Re V.

Open Forum Infect Dis. 2017 Jan 28;4(2):ofx012. doi: 10.1093/ofid/ofx012. eCollection 2017 Spring.

28.

Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES.

Butt AA, Ren Y, Lo Re V 3rd, Taddei TH, Kaplan DE.

Clin Infect Dis. 2017 Jul 1;65(1):64-72. doi: 10.1093/cid/cix224.

PMID:
28369305
29.

Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.

Lo Re V.

Clin Infect Dis. 2017 Feb 15;64(4):498-500. doi: 10.1093/cid/ciw814. No abstract available.

30.

Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).

Lum KJ, Newcomb CW, Roy JA, Carbonari DM, Saine ME, Cardillo S, Bhullar H, Gallagher AM, Lo Re V 3rd.

Eur J Clin Pharmacol. 2017 Jan;73(1):115-123. doi: 10.1007/s00228-016-2148-4. Epub 2016 Oct 27.

PMID:
27787616
31.

Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.

Gowda C, Brown TT, Compher C, Forde KA, Kostman J, Shaw PA, Tien PC, Lo Re V 3rd.

AIDS. 2016 Oct 23;30(16):2519-2528.

32.

HCV epidemiology in high-risk groups and the risk of reinfection.

Midgard H, Weir A, Palmateer N, Lo Re V 3rd, Pineda JA, Macías J, Dalgard O.

J Hepatol. 2016 Oct;65(1 Suppl):S33-S45. doi: 10.1016/j.jhep.2016.07.012. Review.

PMID:
27641987
33.

HIV, Aging, and Viral Coinfections: Taking the Long View.

Taddei TH, Lo Re V 3rd, Justice AC.

Curr HIV/AIDS Rep. 2016 Oct;13(5):269-78. doi: 10.1007/s11904-016-0327-7. Review.

PMID:
27614654
34.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. Epub 2016 Aug 9.

35.

Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.

Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V 3rd, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA.

J Subst Abuse Treat. 2016 Sep;68:62-7. doi: 10.1016/j.jsat.2016.06.002. Epub 2016 Jun 6.

36.

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance.

Lo Re V 3rd, Gowda C, Urick PN, Halladay JT, Binkley A, Carbonari DM, Battista K, Peleckis C, Gilmore J, Roy JA, Doshi JA, Reese PP, Reddy KR, Kostman JR.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):1035-43. doi: 10.1016/j.cgh.2016.03.040. Epub 2016 Apr 5.

37.

Neurological injuries and extracorporeal membrane oxygenation: the challenge of the new ECMO era.

Martucci G, Lo Re V, Arcadipane A.

Neurol Sci. 2016 Jul;37(7):1133-6. doi: 10.1007/s10072-016-2515-z. Epub 2016 Feb 19.

PMID:
26895322
38.

Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.

Bedimo R, Maalouf NM, Lo Re V 3rd.

Curr Opin HIV AIDS. 2016 May;11(3):285-93. doi: 10.1097/COH.0000000000000259. Review.

39.

Reply.

Lo Re V 3rd, Forde KA, Lewis JD, Goldberg DS, Carbonari DM, Roy J, Reddy KR, Sha D, Strom BL, Corley DA.

Clin Gastroenterol Hepatol. 2016 Jun;14(6):918-919. doi: 10.1016/j.cgh.2016.02.013. Epub 2016 Feb 15. No abstract available.

PMID:
26883072
40.

Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone.

Bhattacharya D, Tseng CH, Tate JP, Lo Re V 3rd, Gibert CL, Butt AA, Brown ST, Lim JK, Rodriguez-Barradas MC, Rimland D, Kaufman E, Justice AC, Goetz MB.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):e14-7. doi: 10.1097/QAI.0000000000000941. No abstract available.

41.

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.

Lo Re V 3rd, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Haynes K, Roy JA, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA.

Am J Med. 2016 Mar;129(3):283-91.e5. doi: 10.1016/j.amjmed.2015.10.029. Epub 2015 Nov 17.

42.

Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis.

Lo Re V 3rd, Schuster M.

Ann Intern Med. 2016 Jan 5;164(1):64-5. doi: 10.7326/M15-2722. Epub 2015 Nov 24. No abstract available.

PMID:
26595449
43.

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons.

Gowda C, McKittrick N, Kim D, Kappes RA, Lo Re V 3rd, Tebas P.

AIDS Res Treat. 2015;2015:653840. doi: 10.1155/2015/653840. Epub 2015 Oct 12.

44.

Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.

Rogal SS, Yan P, Rimland D, Lo Re V 3rd, Al-Rowais H, Fried L, Butt AA; Electronically Retrieved Cohort of HCV Infected Veterans Study Group.

Dig Dis Sci. 2016 Mar;61(3):930-6. doi: 10.1007/s10620-015-3918-z. Epub 2015 Nov 2.

PMID:
26526451
45.

Should everyone ageing with HIV take a statin?

Justice A, Freiberg MS, Lo Re V.

Lancet HIV. 2015 Feb;2(2):e36-7. doi: 10.1016/S2352-3018(14)00062-9. Epub 2015 Jan 9. No abstract available.

PMID:
26424457
46.

Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients.

Lo Re V 3rd, Kallan MJ, Tate JP, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park LS, Dubrow R, Reddy KR, Kostman JR, Justice AC, Localio AR.

Open Forum Infect Dis. 2015 Jul 9;2(3):ofv109. doi: 10.1093/ofid/ofv109. eCollection 2015 Sep.

47.

Validity of Primary Immunodeficiency Disease Diagnoses in United States Medicaid Data.

Hernandez-Trujillo H, Orange JS, Roy JA, Wang Y, Newcomb CN, Liu Q, Hennessy S, Lo Re V 3rd.

J Clin Immunol. 2015 Aug;35(6):566-72. doi: 10.1007/s10875-015-0185-x. Epub 2015 Aug 14.

PMID:
26271389
48.

Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).

Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, Wood J, Gallagher AM, Bhullar H, Cardillo S, Hennessy S, Strom BL, Lo Re V 3rd.

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):999-1003. doi: 10.1002/pds.3844. Epub 2015 Jul 27.

PMID:
26213344
49.

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Lo Re V 3rd, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J, Sha D, Marks AR, De Boer J, Schneider JL, Strom BL, Corley DA.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. doi: 10.1016/j.cgh.2015.06.020. Epub 2015 Jun 27.

50.

Marinesco-Sjögren syndrome caused by a new SIL1 frameshift mutation.

Cerami C, Tarantino P, Cupidi C, Annesi G, Lo Re V, Gagliardi M, Piccoli T, Quattrone A.

J Neurol Sci. 2015 Jul 15;354(1-2):112-3. doi: 10.1016/j.jns.2015.04.026. Epub 2015 Apr 24. No abstract available.

PMID:
25982182

Supplemental Content

Support Center